Blog May 12, 2022
While pharmaceutical manufacturers need to continue engaging with the broader healthcare system to help address healthcare disparities in the long term, there is action they can take now.
Blog May 10, 2022
The Institute for Clinical and Economic Review (ICER) recently published the white paper “The Next Generation of Rare Disease Drug Policy: Ensuring Both Innovation and Affordability.” Read on to learn what it means for science manufacturers.
Blog April 28, 2022
Awards matter - to clients, to talent, and to the success of the healthcare communications industry. Hear why from PR expert Elizabeth Stelzer.
Blog April 28, 2022
What the CMS National Coverage Decision Means for the Life Science Industry
Blog April 28, 2022
For many patients, receiving care right away is of vital importance. This post discusses how prior authorization for certain therapies can slow that process down, placing burden on patients and providers, and ultimately, slowing down the treatment process.
Blog April 11, 2022
A strategic marketing communications program that doesn’t include a DE&I lens isn’t strategic. Syneos Health Communications is raising the bar internally and for clients by convening the Syneos DEI Advisory Council to provide insights, consultation, and expertise.
Blog March 29, 2022
COVID-19 has changed the way we think, live, and work. Now, it's important to pause and consider how we continue to evolve, what we retain from the first years of the pandemic, and how we rectify the issues that it helped bring to light.
Blog March 24, 2022
Financial toxicity decreases cancer patients’ quality of life – but early identification and strategic planning can mitigate the impact overall.
Blog March 18, 2022
Patients and healthcare providers are faced with an overwhelming landscape of over-complication, tension, and red tape. We should approach creative brand expression with this in mind, prioritizing clarity in order to remove unnecessary friction around behavior change.
Blog March 9, 2022
We kicked off our series about behavior-changing creative with a few thoughts on authenticity. Next, we’re focusing on bravery. We asked Syneos Health Communications creative leads about the role of bravery in creative expression.
Blog March 3, 2022
For this series, we are focusing on what it takes for creative work to inspire behavior change, which is even more critical when trying to get someone to do something for their benefit.
Blog February 25, 2022
There’s incredible power of a program that is shaped–from beginning to end–by voices from within a community. SPACES showed the world how a small, determined and passionate group of people could work together to change societal views of disability.
Blog February 24, 2022
Collaboration between advocacy groups and the healthcare industry can lead to better treatments, more engaged relationships and better quality of care.
Blog February 21, 2022
Oncologists want to see themselves as enabling both patient and drug success. Whether it is through advertising, or public relations, or medical education – it may be imperative to keep them in the picture in order to earn their interest and engagement with your treatment.
Blog February 10, 2022
With lives dependent upon their decisions, oncologists are left to make treatment decisions for the betterment of their patients all while navigating a growingly crowded and complex landscape. But they shouldn’t have to do it alone.
Blog February 3, 2022
While burnout among HCPs isn’t new, its rapid acceleration is forcing us to address it with a new level of urgency and empathy.
Blog January 27, 2022
To maintain momentum, marketers need to work both sides of the satisfaction equation by reducing perceived cost and frustration and enhancing the emotional benefit.
Blog January 27, 2022
With a global pandemic, rising inflation, and continued political pressures, drug pricing will undoubtedly remain a big focus in 2022.
Blog January 20, 2022
Behavioral science tells us that even the strongest beliefs about the value of change don’t necessarily lead to action. To amplify motivation and cross the threshold from intention to action, we can leverage the fact that we are driven to meet our emotional and social needs.
Blog January 20, 2022
By now, you’ve likely seen the buzz around the Elizabeth Holmes verdict. On January 4, the former CEO and founder of Theranos was found guilty on four of 11 charges of fraud and conspiracy. What can we stand to learn from one of Silicon Valley’s most fascinating frauds?
Blog January 13, 2022
The Consumer Electronics Show (CES) was back in near-full force this year. With healthcare and digital wellness prominent fixtures in this year's event, our trends team has simplified all the signals, innovations, and tech into five need-to-watch themes for 2022.
Blog January 13, 2022
Behavioral science tells us that most decisions are made on an emotional level. As a result, marketers need ways to amplify the perceived emotional benefit of change which often starts with the science of persuasion.
Blog January 7, 2022
Our emotions are powerful drivers in our decision-making. Thanks to behavioral science, it pinpoints more subtle ways that emotions can impact their preference, decisions, and actions and ultimately highlight the steps we need to take to make the most of it.
Blog December 20, 2021
The Institute for Clinical and Economic Review (ICER) recently published its first Assessment of Barriers to Fair Access report examining coverage policies of 15 major commercial insurers
Blog December 9, 2021
The world around us is constantly evolving, which means consumer expectations are too. To stay ahead of what’s to come, we examined several trends reports to curate a selection of the consumer trends that will be most impactful to healthcare brands and audiences.
Blog December 2, 2021
With the seismic shift we’re witnessing with Environmental, Social and Governance (ESG) developments, we know stakeholders are expecting more—encouraging ambitious commitments and exploring the ways to leverage resources, even green financing.
Blog December 2, 2021
Everyone feels differently about weight, weight gain, and health—some welcome interventions while others bristle at them. It’s our job to meet people where they are with what matters most to them.
Blog November 19, 2021
Over the last 18 months, an evolution in diabetes management has accelerated, and for good reason. There are three potential solutions for pharma, device, or DTx marketers to consider based on trends we’ll see in the year ahead.
Blog November 19, 2021
There’s a bigger problem than diabetes—prediabetes, affecting 34.5% of the US adult population (as compared to 10.5% with diabetes), and there’s a likely and significant opportunity for tech to tackle this, with benefits to people and to society.
Blog November 12, 2021
This month policies aimed at lowering drug prices are back on the table. It’s noticeably less ambitious than earlier Democratic proposals, but still represents a historic shift in how drug pricing is approached in the United States.
Already have a RSS feed reader?
